Skip to content

Judith Hooper

3 papers in the library · 14 citations · publishing 2025

Papers

Sort Most recent Most cited

Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study

December 10, 2025 Judith Hooper, Sarah Williams, Raeghan L. Mueller et al. 2 citations preprint

As psychedelic use increases, understanding how demographic and behavioral factors influence the effects of psychedelics is essential for both research and public health. This cross-sectional retrospective study examined 365 people who currently use psilocybin, analyzing differences in acute experiences, psychological outcomes, and substance co-use patterns. Participants were categorized into...

Psilocybin Outside the Clinic

JAMA Psychiatry November 5, 2025 Kent E. Hutchison, Judith Hooper, Hollis C Karoly 10 citations

Importance Psilocybin use has surged in the US following decriminalization efforts and promising clinical trial results. Mirroring early cannabis legalization, public access and enthusiasm are outpacing regulatory oversight and scientific understanding, posing potential risks to public health. Objective To review emerging evidence on the public health implications of unregulated psilocybin...

Preliminary validation and refinement of the psychedelic aesthetic experience questionnaire

Frontiers in Psychology September 15, 2025 Judith Hooper, Jarrod M. Ellingson, Kent E. Hutchison 2 citations

Introduction Aesthetic experiences under psychedelics are often described as vivid, emotionally powerful, and meaningful, yet they remain under-measured in psychometric research. This study aimed to refine and validate the Psychedelic Aesthetic Experience Questionnaire (PAEQ), a novel instrument designed to assess the aesthetic dimensions of acute psychedelic experiences. Methods A total of 365...